Otsuka Holdings Co., Ltd.
Ticker
OTSKF
ISIN
JP318822000
Price
39.48
Change Today
-1.40 / -3.425 %
Price 1 year ago
35.35 / 11.69 %
Market Capitalization
-
52 Week Low
35.35
52 Week High
41.40
200 Day Moving Average
38.08
50-day Moving Average
40.11
Price evolution
Yearly Returns
Peers
Peers
Company information
Summary
Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides BODYMAINTÉ Jelly, a conditioning food product; BODYMAINTÉ Drink, a conditioning beverage; EQUELLE and EQUELLE Gelée, which supports women's health and beauty; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; and OS-1, an oral rehydration solution. In addition, the company offers soft drinks, food products, and wines; clinical testing and medical equipment; cosmetics; warehousing and transport services; chemical products; travel agency services; analysis and measurement equipment; pharmaceutical intermediates; testing equipment, such as vehicle headlight testers; synthetic resin molded products; venture capital services; paper products; artificial turf; ceramic boards, ceramic board masterpiece arts, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; IT solution services; insecticides and toiletry products; and flaky titanate and special compounds. Further, it provides infusion and clinical nutrition products; Xenotransplantation products; hydrazine; plant-based food products, including cheese alternatives, dressings, and desserts; stable isotopes; software and services to enhance management of mental healthcare systems; products for urinary tract health; potassium titanate; bio-pesticides; functional and dietetic foods; spring and mineral water; industrial chemicals; polyolefin foams; anticancer drugs; and adhesive tapes. Additionally, the company operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.
Sector
Healthcare
Industry
Drug Manufacturers—General
Country
Japan
Exchange
-
Earnings Per Share
1.56
P/E Ratio
20.928205
Debt/Equity Ratio
8.806
Beta
0.286779
Ebitda
225,682,997,248.00
Ebitda Margins
0.14
Enterprise to Ebitda
-1.04
Enterprise Value
-233,707,094,016.00
Target Price
-
Estimated Price
-
Book Value
4,232.92
Expected Growth
-
Balance sheet
Income statement
Sustainability
Correlation
Company | Name | Correlation |
---|---|---|
600771.SS | GUANGYUYUAN CHINESE HERBAL MEDI | -0.48 |
LLY | Eli Lilly and Company | -0.47 |
600436.SS | ZHANGZHOU PIENTZEHUANG PHARMACE | -0.43 |
600276.SS | JIANGSU HENGRUI MEDICAL CO LTD | -0.40 |
4519.T | CHUGAI PHARMACEUTICAL CO | -0.39 |
JNJ | Johnson & Johnson | -0.34 |
NOVN.SW | NOVARTIS N | -0.34 |
4503.T | ASTELLAS PHARMA | -0.30 |
AMGN | Amgen Inc. | -0.19 |
BMY | Bristol-Myers Squibb Company | -0.19 |
MRK | Merck & Company, Inc. | -0.18 |
GSK.L | GSK PLC | -0.12 |
GSK | GSK plc | -0.12 |
ABBV | AbbVie Inc. | -0.11 |
HZNP | Horizon Therapeutics Public Lim | -0.07 |
1093.HK | CSPC PHARMA | -0.01 |
GILD | Gilead Sciences, Inc. | 0.00 |
PFE | Pfizer, Inc. | 0.01 |
600572.SS | ZHEJIANG CONBA PHARMACEUTICAL C | 0.05 |
MYX.AX | M PHARMA FPO | 0.06 |
AZN | Astrazeneca PLC | 0.07 |
600867.SS | TONGHUA DONGBAO MEDICINES CO LT | 0.07 |
ECILC.IS | ECZACIBASI ILAC | 0.07 |
600613.SS | SHANGHAI SHENQI PHARM INVEST MA | 0.11 |
300006.SZ | CHONGQING LUMMY PH | 0.13 |
4568.T | DAIICHI SANKYO COMPANY LIMITED | 0.14 |
KLBF.JK | Kalbe Farma Tbk. | 0.22 |
600713.SS | NANJING PHARMACEUTICAL CO LTD | 0.26 |
2186.HK | LUYE PHARMA | 0.28 |
Similar companies
Ticker | Name | City | Country | Currency | Exchange | Beta | EV/EBITDA | Employees | Site |
---|---|---|---|---|---|---|---|---|---|
600276.SS | JIANGSU HENGRUI MEDICAL CO LTD | Lianyungang | China | CNY | SHH | 58.73 | 24491 | https://www.hrs.com.cn | |
KLBF.JK | Kalbe Farma Tbk. | Jakarta | Indonesia | IDR | JKT | 0.50 | 14.50 | 12392 | https://www.kalbe.co.id |
1093.HK | CSPC PHARMA | Shijiazhuang | China | HKD | HKG | 0.67 | 12.86 | 24746 | https://www.cspc.com.hk |
300006.SZ | CHONGQING LUMMY PH | Chongqing | China | CNY | SHZ | 0.83 | -32.33 | 935 | https://www.cqlummy.com |
PFE | Pfizer, Inc. | New York | United States | USD | NYQ | 0.68 | 6.88 | 79000 | https://www.pfizer.com |
600572.SS | ZHEJIANG CONBA PHARMACEUTICAL C | Hangzhou | China | CNY | SHH | 0.46 | 10.69 | 8589 | https://www.conbagroup.com |
600713.SS | NANJING PHARMACEUTICAL CO LTD | Nanjing | China | CNY | SHH | 0.46 | 9.37 | 5062 | https://www.njyy.com |
600867.SS | TONGHUA DONGBAO MEDICINES CO LT | Tonghua | China | CNY | SHH | 0.24 | 12.42 | https://www.thdb.com | |
ECILC.IS | ECZACIBASI ILAC | Istanbul | Turkey | TRY | IST | 0.20 | 71.70 | 336 | https://www.eczacibasi.com.tr/en/eczacibasi-gruop/companies/other-products-and-services |
GSK.L | GSK PLC | Brentford | United Kingdom | GBp | LSE | 0.32 | 6.22 | 90096 | https://www.gsk.com |
MRK | Merck & Company, Inc. | Kenilworth | United States | USD | NYQ | 0.36 | 10.37 | 67000 | https://www.merck.com |
BMY | Bristol-Myers Squibb Company | New York | United States | USD | NYQ | 0.44 | 8.87 | 32200 | https://www.bms.com |
600771.SS | GUANGYUYUAN CHINESE HERBAL MEDI | Xi'an | China | CNY | SHH | 0.55 | -48.11 | 1900 | https://www.guangyuyuan.com |
GILD | Gilead Sciences, Inc. | Foster City | United States | USD | NMS | 0.39 | 7.19 | 14400 | https://www.gilead.com |
JNJ | Johnson & Johnson | New Brunswick | United States | USD | NYQ | 0.57 | 14.45 | 141700 | https://www.jnj.com |
GSK | GSK plc | Brentford | United Kingdom | USD | NYQ | 0.18 | 8.08 | 90096 | https://www.gsk.com |
AZN | Astrazeneca PLC | Cambridge | United Kingdom | USD | NMS | 0.12 | 18.55 | 83100 | https://www.astrazeneca.com |
ABBV | AbbVie Inc. | North Chicago | United States | USD | NYQ | 0.75 | 11.46 | 50000 | https://www.abbvie.com |
2186.HK | LUYE PHARMA | Yantai | China | HKD | HKG | 0.75 | 14.06 | 4845 | https://www.luye.cn |
600613.SS | SHANGHAI SHENQI PHARM INVEST MA | Shanghai | China | CNY | SHH | 0.36 | 22.96 | 1371 | https://www.gzsq.com |
MYX.AX | M PHARMA FPO | Salisbury South | Australia | AUD | ASX | 1.09 | 27.98 | https://www.maynepharma.com | |
4568.T | DAIICHI SANKYO COMPANY LIMITED | Tokyo | Japan | JPY | JPX | 52.12 | 16458 | https://www.daiichisankyo.com | |
4503.T | ASTELLAS PHARMA | Tokyo | Japan | JPY | JPX | 0.58 | 12.39 | 14522 | https://www.astellas.com |
NOVN.SW | NOVARTIS N | Basel | Switzerland | CHF | EBS | 0.50 | 10.30 | 108000 | https://www.novartis.com |
SNY | Sanofi | Paris | France | USD | NMS | 0.36 | 9.75 | 95442 | https://www.sanofi.com |
HZNP | Horizon Therapeutics Public Lim | Dublin | Ireland | USD | NMS | 1.16 | 20.67 | 1940 | https://www.horizontherapeutics.com |
LLY | Eli Lilly and Company | Indianapolis | United States | USD | NYQ | 0.37 | 29.00 | 35000 | https://www.lilly.com |
AMGN | Amgen Inc. | Thousand Oaks | United States | USD | NMS | 0.58 | 12.61 | 24200 | https://www.amgen.com |
4519.T | CHUGAI PHARMACEUTICAL CO | Tokyo | Japan | JPY | JPX | 0.64 | 9.60 | 7664 | https://www.chugai-pharm.co.jp |
600436.SS | ZHANGZHOU PIENTZEHUANG PHARMACE | Zhangzhou | China | CNY | SHH | 0.78 | 57.53 | 2591 | https://www.zzpzh.com.cn |
BAYN.DE | BAYER AG | Leverkusen | Germany | EUR | GER | 1.16 | 13.66 | 101914 | https://www.bayer.com |
AZN.L | ASTRAZENECA PLC ORD SHS $0.25 | Cambridge | United Kingdom | GBp | LSE | 0.10 | 15.96 | 83100 | https://www.astrazeneca.com |
300357.SZ | ZHEJIANG WOLWO BIO | Huzhou | China | CNY | SHZ | 0.40 | 56.57 | 1488 | https://www.wolwobiotech.com |
SAN.PA | SANOFI | Paris | France | EUR | PAR | 0.36 | 9.86 | 95442 | https://www.sanofi.com |
NVS | Novartis AG | Basel | Switzerland | USD | NYQ | 0.49 | 10.62 | 108000 | https://www.novartis.com |
0P6S.IL | BAYER AG | Leverkusen | Germany | EUR | IOB | 1.15 | 9.51 | 100753 | https://www.bayer.com |
CIPLA.NS | CIPLA LTD | Mumbai | India | INR | NSI | 17.91 | https://www.cipla.com | ||
4528.T | ONO PHARMACEUTICAL CO | Osaka | Japan | JPY | JPX | 0.33 | 13.40 | 3687 | https://www.ono-pharma.com |
4536.T | SANTEN PHARMACEUTICAL CO | Osaka | Japan | JPY | JPX | 0.37 | 7.05 | 4315 | https://www.santen.com |
OGN | Organon & Co. | Jersey City | United States | USD | NYQ | 7.83 | 9300 | https://www.organon.com |
Funds
Mutual Fund Holders
Social
Dividends
Ratings
News
Earnings
SEC Filings
Options
Indicators
Glossary
- Momentum
- A technical indicator that measures the rate of change in price movements over a specific period. It indicates the strength or weakness of a price trend.
Assessment: A positive momentum value generally indicates a good trend, while a negative value suggests a weak or downward trend.
- Inertia
- In trading, inertia refers to the tendency of prices to continue moving in their current direction. It suggests that an asset's price will likely maintain its current trend.
Assessment: A higher inertia value is generally considered good, as it indicates a strong and sustained price trend.
- Relative Strength Index (RSI)
- A momentum oscillator that measures the speed and change of price movements. It helps identify overbought or oversold conditions in an asset.
Assessment: An RSI value above 70 is typically considered overbought and may suggest a potential reversal or correction. Conversely, an RSI value below 30 is often considered oversold, indicating a possible upward price correction.
- Fibonacci's Weighted Moving Average
- A technical indicator that assigns different weights to recent data points, giving more significance to recent prices. It helps smooth out price fluctuations and identify trend reversals.
Assessment: The interpretation of the Fibonacci's Weighted Moving Average value depends on its comparison to other moving averages or trendlines. A value above 50 may indicate an uptrend, while a value below 50 may suggest a downtrend.
- Williams %R
- A momentum indicator that measures overbought or oversold conditions in an asset. It shows the relationship of the current closing price to the high-low range over a specified period.
Assessment: Williams %R values above -20 are typically considered overbought and may indicate a potential price reversal. Values below -80 are often viewed as oversold, suggesting a potential price bounce.
- Relative Volatility Index (RVI)
- A technical indicator that measures the volatility of a security by comparing the magnitude of recent price movements to the magnitude of average price changes. It helps identify periods of high or low volatility.
Assessment: A higher RVI value suggests higher volatility, which can provide trading opportunities but also carries increased risk.
- Commodity Channel Index (CCI)
- A versatile indicator that measures the current price level relative to an average price level over a given period. It helps identify overbought or oversold conditions and potential trend reversals.
Assessment: CCI values above 100 are often considered overbought, indicating a potential price correction or reversal. Values below -100 are typically viewed as oversold, suggesting a potential price rebound.